Overcoming Barriers to Personalized Medicine

In the last few decades, medicine has undergone transformative changes driven by advancements in omics technologies - genomics, proteomics, metabolomics, and transcriptomics. These innovations have provided unprecedented insights into the molecular underpinnings of human health and disease, offering the potential to revolutionize the way we diagnose, treat, and prevent illnesses. However, the current regulatory framework governing clinical assays remains rooted in outdated models that do not fully accommodate the possibilities offered by personalized medicine. This manifesto advocates for a fundamental shift in the regulation of clinical assays, proposing the integration of omics technologies to enable physicians to implement personalized medicine effectively.